{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:35:02Z","timestamp":1791988502737,"version":"4.4.0"},"reference-count":52,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.37238","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T16:01:27Z","timestamp":1638806487000},"page":"e2137238","source":"Crossref","is-referenced-by-count":35,"title":["Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System"],"prefix":"10.1001","volume":"4","author":[{"given":"Eric J.","family":"Hawkins","sequence":"first","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"},{"name":"Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Malte","sequence":"additional","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Informatics, Decision-Enhancement, and Analytic Sciences Center, Health Services Research & Development, VA Salt Lake City Health Care System, Salt Lake City, Utah"},{"name":"Program for Addiction Research, Clinical Care, Knowledge, and Advocacy, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Department of Health Systems and Population Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildi J.","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"Center for Care Delivery & Outcomes Research, Health Services Research & Development, Minneapolis VA Health Care System, Minneapolis, Minnesota"},{"name":"Department of Psychiatry, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Drexler","sequence":"additional","affiliation":[{"name":"Office of Mental Health and Suicide Prevention, Veterans Health Administration, Washington, DC"},{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany E.","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Burden","sequence":"additional","affiliation":[{"name":"Office of Mental Health and Suicide Prevention, Veterans Health Administration, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Knoeppel","sequence":"additional","affiliation":[{"name":"Office of Mental Health and Suicide Prevention, Veterans Health Administration, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa N.","family":"Danner","sequence":"additional","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Lott","sequence":"additional","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Liberto","sequence":"additional","affiliation":[{"name":"Office of Mental Health and Suicide Prevention, Veterans Health Administration, Washington, DC"},{"name":"Department of Psychiatry, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[{"name":"Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, Washington"},{"name":"Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, Washington"},{"name":"Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"zoi211052r1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","article-title":"US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.","volume":"46","author":"Unick","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"2","key":"zoi211052r2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA): historical perspective, lessons learned, and next steps.","volume":"39","author":"Wyse","year":"2018","journal-title":"Subst Abus"},{"issue":"35","key":"zoi211052r3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","article-title":"Vital signs: characteristics of drug overdose deaths involving opioids and stimulants - 24 states and the District of Columbia, January-June 2019.","volume":"69","author":"O\u2019Donnell","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6408","key":"zoi211052r4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"10159","key":"zoi211052r5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"zoi211052r7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/jama.2020.17694","article-title":"Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak.","volume":"324","author":"Wainwright","year":"2020","journal-title":"JAMA"},{"issue":"16","key":"zoi211052r8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic.","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"zoi211052r9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/add.2011.106.issue-1","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"4","key":"zoi211052r10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.v111.4","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial.","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"zoi211052r11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence.","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"1-2","key":"zoi211052r12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.","volume":"108","author":"Meader","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi211052r13","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"issue":"10208","key":"zoi211052r14","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action.","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"zoi211052r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6373","article-title":"Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder.","volume":"2","author":"Haffajee","year":"2019","journal-title":"JAMA Netw Open"},{"key":"zoi211052r17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jsat.2019.07.013","article-title":"Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact.","volume":"108","author":"Miele","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi211052r18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13722-019-0135-7","article-title":"Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.","volume":"14","author":"McNeely","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"zoi211052r19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jama.2018.8826","article-title":"Helping to end addiction over the long-term: the research plan for the NIH HEAL initiative.","volume":"320","author":"Collins","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi211052r20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08897077.2021.1891600","article-title":"\u201cOne size does not fit all\u201d and other lessons learned from grants for implementation of the AHRQ medication assisted treatment for opioid use disorder in rural primary care.","volume":"42","author":"Nourjah","year":"2021","journal-title":"Subst Abus"},{"key":"zoi211052r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108277","article-title":"Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults.","volume":"128","author":"Elkington","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"zoi211052r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108327","article-title":"Introduction to the special issue on the HEALing Communities Study.","volume":"217","author":"El-Bassel","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"zoi211052r23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2019.07.014","article-title":"Preliminary results of the evaluation of the California Hub and Spoke Program.","volume":"108","author":"Darfler","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi211052r24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder: a scoping review.","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"key":"zoi211052r25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jsat.2019.07.007","article-title":"The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.","volume":"108","author":"Reif","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi211052r26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: development, implementation, and impact.","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J Addict Med"},{"key":"zoi211052r27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jsat.2019.06.015","article-title":"Implementation and evaluation of Missouri\u2019s Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.","volume":"108","author":"Winograd","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"zoi211052r28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jsat.2019.05.005","article-title":"West Virginia\u2019s model of buprenorphine expansion: preliminary results.","volume":"108","author":"Winstanley","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi211052r29","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements.","volume":"13","author":"Penfold","year":"2013","journal-title":"Acad Pediatr"},{"issue":"3","key":"zoi211052r30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.","volume":"41","author":"Gordon","year":"2020","journal-title":"Subst Abus"},{"key":"zoi211052r31","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s11606-020-06260-9","article-title":"A research agenda for advancing strategies to improve opioid safety: findings from a VHA state of the art conference.","volume":"35","author":"Becker","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi211052r32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1037\/0022-006X.69.3.429","article-title":"Strike while the iron is hot: can stepped-care treatments resurrect relapsing smokers?","volume":"69","author":"Smith","year":"2001","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"zoi211052r33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1037\/0022-006X.68.4.573","article-title":"Stepped care as a heuristic approach to the treatment of alcohol problems.","volume":"68","author":"Sobell","year":"2000","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"zoi211052r34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/(ISSN)1097-4679","article-title":"Self-administered treatment in stepped-care models of depression treatment.","volume":"59","author":"Scogin","year":"2003","journal-title":"J Clin Psychol"},{"issue":"9 pt 2","key":"zoi211052r35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00016","article-title":"Stepped care for back pain: activating approaches for primary care.","volume":"134","author":"Von Korff","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi211052r36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1037\/0022-006X.68.4.549","article-title":"Recommendations for a cost-offset model of psychotherapy allocation using generalized anxiety disorder as an example.","volume":"68","author":"Newman","year":"2000","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"zoi211052r37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research.","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"zoi211052r38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial.","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi211052r39","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1093\/ije\/dyy135","article-title":"The use of controls in interrupted time series studies of public health interventions.","volume":"47","author":"Lopez Bernal","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"12","key":"zoi211052r40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"2","key":"zoi211052r41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: results at 2-5 years.","volume":"17","author":"Fiellin","year":"2008","journal-title":"Am J Addict"},{"issue":"5","key":"zoi211052r42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.","volume":"171","author":"Alford","year":"2011","journal-title":"Arch Intern Med"},{"key":"zoi211052r43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-Based Opioid Treatment with Buprenorphine (OBOT-B): statewide implementation of the Massachusetts collaborative care model in community health centers.","volume":"60","author":"LaBelle","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"zoi211052r44","doi-asserted-by":"publisher","author":"Harvey","year":"2016","DOI":"10.1186\/s13012-016-0398-2"},{"key":"zoi211052r45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project.","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"issue":"1","key":"zoi211052r46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13722-021-00263-5","article-title":"Clinical leaders and providers\u2019 perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs\u2019 facilities.","volume":"16","author":"Hawkins","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"zoi211052r49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13722-021-00218-w","article-title":"PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.","volume":"16","author":"Campbell","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"zoi211052r50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0306-4603(94)00072-7","article-title":"Initial motivations for alcohol treatment: relations with patient characteristics, treatment involvement, and dropout.","volume":"20","author":"Ryan","year":"1995","journal-title":"Addict Behav"},{"issue":"8","key":"zoi211052r51","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2105\/AJPH.94.8.1418","article-title":"Gender differences in substance use treatment entry and retention among prisoners with substance use histories.","volume":"94","author":"Pelissier","year":"2004","journal-title":"Am J Public Health"},{"issue":"9","key":"zoi211052r52","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework.","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"key":"zoi211052r16","year":"2019"},{"key":"zoi211052r47","volume-title":"Facilitation of the Stepped-Care Model and Medication Treatment for Opioid Use Disorder.","author":"Gordon","year":"2018"},{"key":"zoi211052r48","volume-title":"Evaluating the Implementation of the VA Stepped Care for Opioid Use Disorder","author":"Hawkins","year":"2018"},{"key":"zoi211052r6","unstructured":"Ahmad? FB, Rossen? LM, Sutton? P. Provisional drug overdose counts. Accessed October 8, 2020. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm#data-tables"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2786900\/hawkins_2021_oi_211052_1661521371.62903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T15:00:43Z","timestamp":1662044443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2786900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.37238","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}